Studies revealed that KIR2DL4 activates the cytotoxicity of NK cells (Faure and Long, 2002), and NK-92 cells stimulated with KIR2DL4 had higher cytotoxicity against breast cancer cells (Kilic et al., 2023). The gene discussed is KIR2DL4; the disease is breast carcinoma.